top of page

Browse by category

Search

Journal Watch 15/5/2025

Journal Watch 15/5/2025

Journal Watch 15/5/2025

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Gastric bypass associated with a lower incidence of MACE vs. sleeve gastrectomy over an 11-year follow-up

Gastric bypass associated with a lower incidence of MACE vs. sleeve gastrectomy over an 11-year follow-up

Gastric bypass associated with a lower incidence of MACE vs. sleeve gastrectomy over an 11-year follow-up

Gastric bypass (GB) is associated with a lower incidence of major adverse cardiac events (MACE) compared to sleeve gastrectomy (SG) over...

SOUL trial: Oral semaglutide demonstrates a 14% reduction in risk of major adverse CV events

SOUL trial: Oral semaglutide demonstrates a 14% reduction in risk of major adverse CV events

SOUL trial: Oral semaglutide demonstrates a 14% reduction in risk of major adverse CV events

Headline results from the SOUL cardiovascular outcomes trial show the trial achieved its primary objective by demonstrating a...

Semaglutide cardiovascular benefits are maintained in people with impaired kidney function

Semaglutide cardiovascular benefits are maintained in people with impaired kidney function

Semaglutide cardiovascular benefits are maintained in people with impaired kidney function

Semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults...

World’s first bariatric robotic telesurgery performed in India

3 days ago

Rhythm’s Bivamelagon achieved statistically significant and clinically meaningful reductions in BMI in patients with hypothalamic obesity

3 days ago

Disordered eating behaviours in males linked to prescription weight-loss medications

3 days ago

Back to Top

bottom of page